Form: 10-Q

Quarterly report pursuant to Section 13 or 15(d)

May 15, 2003

EXHIBIT 99.2

Published on May 15, 2003

EXHIBIT 99.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002


A signed original of this written statement required by
Section 906 has been provided to Access Pharmaceuticals, Inc.
and will be retained by Access Pharmaceuticals, Inc. and
furnished to the SEC or its staff upon its request.

The undersigned, Stephen B. Thompson, Chief Financial Officer
of Access Pharmaceuticals, Inc. (the "Company"), hereby
certifies that to his knowledge the Quarterly Report on Form
10-Q for the period ended March 31, 2003 of the Company filed
with the Securities and Exchange Commission on the date hereof
(the "Report") fully complies with the requirements of section
13(a) or 15(d) of the Securities Exchange Act of 1934 and the
information contained in the Report fairly presents, in all
material respects, the financial condition and results of
operations of the Company for the period specified.

This information shall not be deemed to be "filed" for the
purposes of Section 18 of the Securities Exchange Act of 1934
and shall not be deemed to be incorporated by reference in any
filing under the Securities Act of 1933.

Signed at the City of Dallas, in the State of Texas, this
14th day of May, 2003.


/s/ Stephen B. Thompson
- -----------------------
Stephen B. Thompson
Chief Financial Officer